D-1306-2020 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1306-2020 was initiated by Pfizer Inc. on May 29, 2020 and is designated Class II. Reason for recall: Presence of Particulate Matter: particulate matter identified after reconstitution. The recall status is terminated (terminated Jan 13, 2022). Affected quantity: 94320 units.

Recall details

Product Type
Drugs
Report Date
Jun 17, 2020
Initiation Date
May 29, 2020
Termination Date
Jan 13, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
94320 units

Product description

Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83

Reason for recall

Presence of Particulate Matter: particulate matter identified after reconstitution.

Distribution pattern

Distributed Nationwide in the US

Code information

Lot # 3301612, EXP 02/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1306-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1306-2020. Report a data issue: hello@regdatalab.com.